Christophe co-founded Geno in 1998, and served as CEO from May 2009 until December 2024, during which he led Geno’s mission to accelerate the transition to more sustainable materials, turning vision into reality - creating, scaling and commercializing multiple award-winning technologies delivering measurable impact across the US, Europe, and Asia on an economically competitive basis to fossil fuel based alternatives. Today he serves Geno in an active and engaged Founder capacity supporting strategic growth initiatives, while also serving as Chairman of the Board of our Future Origins joint venture. Christophe is Chair Emeritus and Board member of Biocom, the largest advocacy organization for California’s life sciences sector, and has served on BIO’s Industrial & Environmental Section Governing Board. He is also a member of YPO, an international leadership organization for chief executives, and previously served on the World Economic Forum Global Agenda Council on Biotechnology. In 2024 he was named by Forbes as one of the top 50 global sustainability leaders. Christophe holds a Ph.D. in bioengineering from the University of California, San Diego and earned a B.S. in biomedical engineering from Duke University.

‍